Bioventus Inc.
BVS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$0 | -$121 | -$145 | $11 |
| Dep. & Amort. | $50 | $57 | $55 | $35 |
| Deferred Tax | -$5 | -$2 | -$47 | -$10 |
| Stock-Based Comp. | $10 | $3 | $18 | $20 |
| Change in WC | -$12 | -$3 | -$30 | -$15 |
| Other Non-Cash | -$3 | $82 | $135 | -$18 |
| Operating Cash Flow | $39 | $15 | -$14 | $23 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$7 | -$1 | -$14 |
| Net Acquisitions | $0 | $35 | $0 | -$263 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $24 | -$12 | -$115 | -$7 |
| Investing Cash Flow | $23 | $16 | -$116 | -$284 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$60 | -$23 | $60 | $166 |
| Stock Issued | $2 | $1 | $6 | $109 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | -$0 |
| Other Fin. Act. | $3 | -$4 | -$3 | -$2 |
| Financing Cash Flow | -$55 | -$27 | $62 | $273 |
| Forex Effect | -$3 | $1 | $1 | -$0 |
| Net Chg. in Cash | $5 | $5 | -$67 | $12 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $37 | $32 | $99 | $87 |
| End Cash | $42 | $37 | $32 | $99 |
| Free Cash Flow | $38 | $8 | -$15 | $2 |